The Precision Peptide Company has launched seven peptide products for direct purchase online across all 50 U.S. states, including capsules, a topical serum, and a transdermal patch called The Recovery Patch. This patch is the company's first needle-free, no-mix, no-refrigeration product aimed at active consumers. The platform is supported by LegitScript certification ensuring compliance and safety, and the company plans to add GLP-1, Sermorelin, and NAD+ protocols soon through its telehealth and compounding infrastructure. Recently, the FDA's Pharmacy Compounding Advisory Committee voted favorably on six of seven peptides reviewed, four of which are in the company's existing formulations, though these recommendations are non-binding and not FDA approvals.
Ferrari reported Q2 2026 net revenues of €1.94 billion, up 8% year-on-year, driven by a richer product mix and increased personalization sales. Operating profit rose 10% to €605 million with a margin of 31.2%, while net profit grew 9% to €463 million...
Dimensional Fund Advisors Ltd. has publicly disclosed holding a 1.58% stake in Gamma Communications PLC as of July 29, 2026. The disclosure, made under Rule 8.3 of the Takeover Code, indicates ownership of 1,414,785 ordinary shares. This filing is a ...
CallTower has introduced its Enterprise Concierge Program, a premium service designed to offer personalized, high-touch support for large-scale organizations. The program includes strategic pre-sales planning, dedicated project management, and enhanc...
CCC Intelligent Solutions Holdings Inc. announced a 10% revenue increase to $285.9 million in Q2 2026, driven by growing adoption of its AI-powered insurance platform. The company reported a 40% adjusted EBITDA margin and expanded contracts with top ...
USANA Health Sciences announced positive results from a 12-week consumer study of its Glow skincare supplement, showing over 97% of participants reported brighter, more radiant, and more even-toned skin. The study involved 36 participants from the US...
